Scilex Holding SCLX
NASDAQ SCLX
$5.20 -0.17 (-3.17%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) EBT (2020 - 2026)

Scilex Holding (SCLX) posted EBT of -$115.0 million for Q2 2026, down 151.87% on a QoQ basis from -$45.6 million in Q1 2026, and down 161.14% year-over-year from $188.0 million in Q2 2025.

Analysis

Scilex Holding (SCLX) EBT (2020 - 2026) Analysis & Trends

Scilex Holding has reported EBT for 7 years, with the latest figure at -$115.0 million in Q2 2026.

  • On a quarterly basis, EBT fell 161.14% year-over-year to -$115.0 million in Q2 2026; TTM through Jun 2026 was -$464.5 million, a 473.81% decrease from a year earlier, with the FY2025 full-year figure at -$374.0 million, down 413.72% from the prior year.
  • EBT was -$115.0 million for Q2 2026 at Scilex Holding, down from -$45.6 million in the prior quarter.
  • The five-year high for EBT was $21.5 million in Q3 2022, with the low at -$257.8 million in Q3 2025.
  • Average EBT over 5 years is -$41.4 million, with a median of -$26.4 million recorded in 2023.
  • The largest YoY upside for EBT was 7732.69% in 2022 against a maximum downside of 10705.02% in 2022.
  • Over 5 years, EBT stood at -$17.8 million in 2022, then retreated by 19.88% to -$21.4 million in 2023, then soared by 69.8% to -$6.5 million in 2024, then sank by 613.5% to -$46.1 million in 2025, then sank by 149.42% to -$115.0 million in 2026.
  • The last three EBT figures came in at -$115.0 million (Q2 2026), -$45.6 million (Q1 2026), and -$46.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 6.75 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 4.28 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -683.00 Mn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 4.27 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -653.00 Mn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 1.64 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - -644.37 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 751.51 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 372.70 Mn
10 Scilex Holding 35.91 Mn -76.88 Mn 3.97 Mn -114.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -114.98 Mn
Mar 31, 2026 -45.65 Mn
Dec 31, 2025 -46.10 Mn
Sep 30, 2025 -257.82 Mn
Jun 30, 2025 -44.03 Mn
Mar 31, 2025 -26.08 Mn
Dec 31, 2024 -6.46 Mn
Sep 30, 2024 -4.39 Mn
Jun 30, 2024 -37.58 Mn
Mar 31, 2024 -24.38 Mn
Dec 31, 2023 -21.39 Mn
Sep 30, 2023 -35.53 Mn
Jun 30, 2023 -26.65 Mn
Mar 31, 2023 -30.75 Mn
Dec 31, 2022 -17.84 Mn
Sep 30, 2022 21.49 Mn
Jun 30, 2022 -17.87 Mn
Mar 31, 2022 -9.14 Mn
Dec 31, 2021 -35.26 Mn
Sep 30, 2021 -281,552.00